| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Apr 02, 2024 | Sale | $9.88 | 1,357 | 13,407 | 117,004 | Apr 03, 2024, 04:13 PM | |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | Apr 02, 2024 | Sale | $9.86 | 12,115 | 119,454 | 322,839 | Apr 03, 2024, 04:10 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Feb 21, 2024 | Sale | $7.45 | 3,966 | 29,547 | 118,361 | Feb 22, 2024, 04:36 PM | |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | Feb 21, 2024 | Sale | $7.46 | 13,033 | 97,226 | 334,954 | Feb 22, 2024, 04:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 21, 2024 | Sale | $7.46 | 3,764 | 28,079 | 175,669 | Feb 22, 2024, 04:32 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Feb 20, 2024 | Sale | $7.68 | 602 | 4,623 | 90,992 | Feb 22, 2024, 04:30 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Feb 21, 2024 | Sale | $7.47 | 3,365 | 25,137 | 87,627 | Feb 22, 2024, 04:30 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Jan 17, 2024 | Sale | $7.15 | 2,543 | 18,182 | 72,327 | Jan 19, 2024, 04:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Jan 17, 2024 | Sale | $7.18 | 1,266 | 9,090 | 53,094 | Jan 19, 2024, 04:32 PM | |
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Oct 03, 2023 | Sale | $6.99 | 13,567 | 94,833 | 149,433 | Oct 05, 2023, 04:41 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Sep 15, 2023 | Sale | $6.45 | 15,500 | 99,930 | 64,860 | Sep 18, 2023, 04:44 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Jul 06, 2023 | Sale | $10.80 | 5,500 | 59,400 | 59,860 | Jul 10, 2023, 04:42 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Jun 30, 2023 | Option Exercise | $7.13 | 10,000 | 71,300 | 70,360 | Jul 05, 2023, 04:32 PM | |
| VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | President and CEO | Apr 03, 2023 | Sale | $7.83 | 7,437 | 58,232 | 214,618 | Apr 05, 2023, 05:04 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Apr 03, 2023 | Sale | $7.83 | 1,259 | 9,858 | 71,617 | Apr 05, 2023, 05:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Mar 20, 2023 | Sale | $7.76 | 2,193 | 17,018 | 65,360 | Mar 22, 2023, 04:49 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Mar 20, 2023 | Sale | $7.76 | 3,654 | 28,355 | 72,876 | Mar 22, 2023, 04:48 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Mar 20, 2023 | Sale | $7.76 | 4,410 | 34,222 | 102,200 | Mar 22, 2023, 04:47 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Mar 15, 2023 | Sale | $8.20 | 15,373 | 126,059 | 76,530 | Mar 17, 2023, 04:37 PM | |
| VYGR | Voyager Therapeutics, Inc. | NEUROCRINE BIOSCIENCES INC | 10% Owner | Feb 23, 2023 | Buy | $8.88 | 4,395,588 | 39,032,822 | 8,575,316 | Feb 24, 2023, 06:15 AM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Feb 17, 2023 | Sale | $7.45 | 3,297 | 24,563 | 106,610 | Feb 22, 2023, 08:58 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Feb 17, 2023 | Sale | $7.45 | 738 | 5,498 | 67,553 | Feb 22, 2023, 08:57 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Feb 13, 2023 | Sale | $7.67 | 797 | 6,113 | 34,291 | Feb 15, 2023, 04:53 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Feb 13, 2023 | Sale | $7.67 | 2,868 | 21,998 | 109,907 | Feb 15, 2023, 04:52 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Jan 31, 2023 | Sale | $9.25 | 185,000 | 1,711,250 | 4,813,933 | Feb 01, 2023, 07:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Feb 01, 2023 | Sale | $9.32 | 128,642 | 1,198,943 | 4,685,291 | Feb 01, 2023, 07:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Jan 30, 2023 | Sale | $9.03 | 75,000 | 677,250 | 4,998,933 | Feb 01, 2023, 07:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures GP III, L.P. | 10% Owner | Jan 27, 2023 | Sale | $9.02 | 50,000 | 451,000 | 5,073,933 | Jan 31, 2023, 04:30 PM | |
| VYGR | Voyager Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Jan 24, 2023 | Sale | $9.27 | 100,000 | 927,000 | 5,173,933 | Jan 26, 2023, 05:23 PM | |
| VYGR | Voyager Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Jan 25, 2023 | Sale | $9.22 | 50,000 | 461,000 | 5,123,933 | Jan 26, 2023, 05:23 PM | |
| VYGR | Voyager Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Jan 20, 2023 | Sale | $9.15 | 100,000 | 915,000 | 5,328,933 | Jan 24, 2023, 06:20 PM | |
| VYGR | Voyager Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Jan 23, 2023 | Sale | $9.06 | 55,000 | 498,300 | 5,273,933 | Jan 24, 2023, 06:20 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Jan 17, 2023 | Sale | $9.85 | 2,188 | 21,549 | 113,567 | Jan 19, 2023, 04:57 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Jan 17, 2023 | Sale | $9.85 | 1,106 | 10,892 | 35,488 | Jan 19, 2023, 04:55 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Jan 17, 2023 | Sale | $9.85 | 2,188 | 21,549 | 52,695 | Jan 19, 2023, 04:53 PM | |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | Jan 10, 2023 | Sale | $8.05 | 336,400 | 2,709,433 | 3,961,507 | Jan 11, 2023, 06:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | Jan 11, 2023 | Sale | $8.50 | 110,000 | 934,615 | 3,851,507 | Jan 11, 2023, 06:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | Jan 09, 2023 | Sale | $7.67 | 456,000 | 3,498,295 | 4,297,907 | Jan 11, 2023, 06:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Dec 31, 2022 | Option Exercise | $5.17 | 388 | 2,006 | 36,582 | Jan 10, 2023, 04:07 PM | |
| VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Chief Scientific Officer | Jan 06, 2023 | Sale | $6.41 | 388 | 2,487 | 36,194 | Jan 10, 2023, 04:07 PM | |
| VYGR | Voyager Therapeutics, Inc. | Third Rock Ventures III, L.P. | 10% Owner | Aug 24, 2022 | Sale | $6.09 | 149,972 | 913,330 | 5,628,933 | Aug 26, 2022, 04:15 PM | |
| VYGR | Voyager Therapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Aug 25, 2022 | Sale | $6.22 | 200,000 | 1,244,000 | 5,428,933 | Aug 26, 2022, 04:15 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Aug 16, 2022 | Sale | $6.04 | 128,456 | 775,874 | 5,778,905 | Aug 18, 2022, 04:15 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Aug 12, 2022 | Sale | $6.12 | 348,007 | 2,129,803 | 6,043,169 | Aug 16, 2022, 04:22 PM | |
| VYGR | Voyager Therapeutics, Inc. | TRV GP III, LLC | 10% Owner | Aug 15, 2022 | Sale | $6.04 | 135,808 | 820,280 | 5,907,361 | Aug 16, 2022, 04:22 PM | |
| VYGR | Voyager Therapeutics, Inc. | PIERCE GLENN | Director | Jul 14, 2022 | Sale | $6.70 | 9,512 | 63,730 | 16,788 | Jul 18, 2022, 05:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | Higgins Michael J | Director | Jul 14, 2022 | Sale | $6.70 | 13,891 | 93,070 | 31,314 | Jul 18, 2022, 05:32 PM | |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | Jun 21, 2022 | Buy | $5.28 | 101,400 | 535,504 | 4,377,907 | Jun 23, 2022, 05:21 PM | |
| VYGR | Voyager Therapeutics, Inc. | EcoR1 Capital, LLC | 10% Owner | Jun 23, 2022 | Buy | $5.66 | 376,000 | 2,126,543 | 4,753,907 | Jun 23, 2022, 05:21 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Apr 04, 2022 | Sale | $8.25 | 1,527 | 12,598 | 52,060 | Apr 06, 2022, 04:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Apr 04, 2022 | Sale | $8.25 | 2,786 | 22,985 | 114,963 | Apr 06, 2022, 04:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Chief Operating Officer | Mar 21, 2022 | Sale | $8.29 | 4,413 | 36,604 | 53,638 | Mar 23, 2022, 06:40 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Mar 21, 2022 | Sale | $8.29 | 4,955 | 41,100 | 117,807 | Mar 23, 2022, 06:39 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Mar 21, 2022 | Sale | $8.29 | 2,649 | 21,972 | 52,489 | Mar 23, 2022, 06:36 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Feb 17, 2022 | Sale | $3.55 | 4,100 | 14,555 | 122,704 | Feb 22, 2022, 04:37 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Feb 17, 2022 | Sale | $3.55 | 789 | 2,801 | 55,107 | Feb 22, 2022, 04:35 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Feb 11, 2022 | Sale | $3.36 | 3,252 | 10,927 | 126,804 | Feb 15, 2022, 04:42 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Feb 11, 2022 | Sale | $3.36 | 361 | 1,213 | 55,896 | Feb 15, 2022, 04:40 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Dec 31, 2021 | Option Exercise | $2.30 | 3,063 | 7,045 | 49,585 | Jan 14, 2022, 06:14 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Jan 03, 2022 | Sale | $2.83 | 3,063 | 8,668 | 46,522 | Jan 14, 2022, 06:14 PM | |
| VYGR | Voyager Therapeutics, Inc. | Burek Julie | VP, Finance | Jan 12, 2022 | Sale | $3.06 | 265 | 811 | 46,257 | Jan 14, 2022, 06:14 PM | |
| VYGR | Voyager Therapeutics, Inc. | Khwaja Omar | See remarks | May 21, 2021 | Sale | $4.03 | 3,516 | 14,169 | 120,509 | May 25, 2021, 04:31 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Apr 05, 2021 | Sale | $4.95 | 3,292 | 16,295 | 110,056 | Apr 07, 2021, 05:44 PM | |
| VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Feb 11, 2021 | Sale | $7.55 | 3,186 | 24,054 | 45,894 | Feb 16, 2021, 04:10 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Feb 11, 2021 | Sale | $7.55 | 3,186 | 24,054 | 49,348 | Feb 16, 2021, 04:08 PM | |
| VYGR | Voyager Therapeutics, Inc. | Khwaja Omar | See remarks | Feb 11, 2021 | Sale | $7.55 | 3,475 | 26,236 | 53,025 | Feb 16, 2021, 04:06 PM | |
| VYGR | Voyager Therapeutics, Inc. | Turenne Andre | President & CEO | Feb 11, 2021 | Sale | $7.55 | 7,977 | 60,226 | 148,375 | Feb 16, 2021, 12:00 AM | |
| VYGR | Voyager Therapeutics, Inc. | Turenne Andre | President & CEO | Jan 12, 2021 | Sale | $8.62 | 10,443 | 90,019 | 156,352 | Jan 14, 2021, 05:59 PM | |
| VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Jan 12, 2021 | Sale | $8.62 | 2,942 | 25,360 | 49,080 | Jan 14, 2021, 05:57 PM | |
| VYGR | Voyager Therapeutics, Inc. | Khwaja Omar | See remarks | May 21, 2020 | Sale | $12.96 | 3,500 | 45,360 | 56,500 | May 22, 2020, 06:15 PM | |
| VYGR | Voyager Therapeutics, Inc. | Hesslein Robert W. | Senior VP & General Counsel | Apr 03, 2020 | Sale | $8.51 | 3,091 | 26,304 | 52,534 | Apr 07, 2020, 05:24 PM | |
| VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Jan 21, 2020 | Sale | $13.36 | 3,128 | 41,790 | 24,522 | Jan 29, 2020, 05:27 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ottmer Matthew P. | Chief Operating Officer | Jan 21, 2020 | Sale | $13.36 | 3,724 | 49,753 | 26,276 | Jan 29, 2020, 05:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | Turenne Andre | President & CEO | Jan 21, 2020 | Sale | $13.36 | 10,705 | 143,019 | 85,545 | Jan 29, 2020, 05:26 PM | |
| VYGR | Voyager Therapeutics, Inc. | NEUROCRINE BIOSCIENCES INC | 10% Owner | Mar 12, 2019 | Buy | $11.96 | 4,179,728 | 49,999,995 | 4,179,728 | Mar 14, 2019, 04:34 PM | |
| VYGR | Voyager Therapeutics, Inc. | PIERCE GLENN | Director | Sep 12, 2018 | Buy | $18.44 | 5,000 | 92,200 | 5,000 | Sep 12, 2018, 12:00 AM | |
| VYGR | Voyager Therapeutics, Inc. | GERAGHTY JAMES A | Director | Sep 10, 2018 | Buy | $19.39 | 3,000 | 58,170 | 76,588 | Sep 12, 2018, 12:00 AM | |
| VYGR | Voyager Therapeutics, Inc. | GERAGHTY JAMES A | Director | Aug 17, 2018 | Buy | $18.31 | 3,000 | 54,930 | 73,588 | Aug 21, 2018, 04:05 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Apr 10, 2018 | Sale | $18.38 | 2,451 | 45,049 | 0 | Apr 12, 2018, 04:01 PM | |
| VYGR | Voyager Therapeutics, Inc. | Henderson Jane | Sr. V.P. & CFO, Corp. Dev. | Mar 22, 2018 | Option Exercise | $16.52 | 39,800 | 657,496 | 19,900 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Henderson Jane | Sr. V.P. & CFO, Corp. Dev. | Mar 23, 2018 | Sale | $16.25 | 22,400 | 363,888 | 11,200 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Henderson Jane | CFO & SVP, Corp. Dev. | Mar 16, 2018 | Option Exercise | $17.06 | 30,832 | 525,994 | 15,416 | Mar 20, 2018, 05:43 PM | |
| VYGR | Voyager Therapeutics, Inc. | Henderson Jane | CFO & SVP, Corp. Dev. | Mar 19, 2018 | Option Exercise | $16.87 | 3,800 | 64,087 | 1,900 | Mar 20, 2018, 05:43 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Mar 12, 2018 | Sale | $25.16 | 2,451 | 61,667 | 2,451 | Mar 14, 2018, 04:07 PM | |
| VYGR | Voyager Therapeutics, Inc. | Sah Dinah Ph.D. | Chief Scientific Officer | Feb 27, 2018 | Sale | $19.99 | 31,246 | 624,535 | 154,311 | Mar 01, 2018, 06:00 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Feb 12, 2018 | Sale | $18.24 | 2,451 | 44,706 | 4,902 | Feb 13, 2018, 04:10 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Jan 10, 2018 | Sale | $16.40 | 3,630 | 59,532 | 7,353 | Jan 12, 2018, 08:57 AM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Dec 11, 2017 | Sale | $13.63 | 5,490 | 74,829 | 10,983 | Dec 13, 2017, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Nov 10, 2017 | Sale | $13.26 | 5,490 | 72,797 | 16,473 | Nov 13, 2017, 04:15 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Oct 10, 2017 | Sale | $20.33 | 10,980 | 223,223 | 21,963 | Oct 12, 2017, 07:28 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Jul 20, 2017 | Sale | $10.00 | 5,490 | 54,900 | 49,413 | Sep 13, 2017, 05:23 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Sep 11, 2017 | Sale | $14.30 | 10,980 | 157,014 | 32,943 | Sep 13, 2017, 05:23 PM | |
| VYGR | Voyager Therapeutics, Inc. | Ravina Bernard | Chief Medical Officer | Sep 05, 2017 | Sale | $10.00 | 5,490 | 54,900 | 17,157 | Sep 06, 2017, 04:38 PM | |
| VYGR | Voyager Therapeutics, Inc. | PAUL STEVEN M | President and CEO | Jan 14, 2016 | Buy | $14.07 | 10,000 | 140,690 | 872,351 | Jan 15, 2016, 05:01 PM | |
| VYGR | Voyager Therapeutics, Inc. | Sanofi | Former 10% owner | Nov 16, 2015 | Buy | $14.00 | 125,000 | 1,750,000 | 2,477,941 | Nov 18, 2015, 02:26 PM |
Menu